NASDAQ:CTIC   CTI BioPharma Corp
CTI BioPharma Corp. , a biopharmaceutical company, focuses on acquiring, developing, and commercializing novel targeted therapies for blood-related cancers in the United States.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.